Trial Profile
Phase I/II Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2010 Trial details were reported at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO 2010).
- 30 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.
- 30 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.